SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Techniclone (TCLN)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Terry D. who wrote (3694)5/8/2005 8:42:02 PM
From: Maurice Winn  Read Replies (1) of 3702
 
Hi Terry. It's nice that life has happy outcomes sometimes. The more the merrier.

image.blog.livedoor.jp

What a great scene. Tarken and girlfriend saw that in Canada.

What's annoying is that Rituxan is now considered a useful adjunct therapy to intermediate grade NHL and I dare say Zevalin [or whatever it's now called is too]. But the medical guilds are too slow for too many people. Due process you know.

Oncolym never made it and Cotara floundered around.

Things should move faster. Much faster. Time is of the essence.

Mqurice
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News